Latest Hollis-Eden Pharmaceuticals Inc. Stories

2010-02-17 15:03:00

SAN DIEGO, Feb. 17 /PRNewswire-FirstCall/ -- Hollis-Eden Pharmaceuticals, Inc. (Nasdaq: HEPH), today announced that it has changed its name to Harbor BioSciences, Inc. and that its ticker symbol will change from 'HEPH' to 'HRBR' on Thursday, February 18, 2010.

2009-11-16 08:00:00

BOSTON, Nov. 16 /PRNewswire-FirstCall/ -- Hollis-Eden Pharmaceuticals, Inc. (Nasdaq: HEPH), today reported preliminary results of its ongoing Phase I/II clinical trial with Apoptone® (HE3235) for hormone-resistant prostate cancer (also called castrate-resistant prostate cancer or CRPC).

2009-09-16 07:30:00

SAN DIEGO, Sept. 16 /PRNewswire-FirstCall/ -- Hollis-Eden Pharmaceuticals, Inc.

2009-06-15 06:05:00

SAN DIEGO, June 15 /PRNewswire-FirstCall/ -- Hollis-Eden Pharmaceuticals, Inc. (Nasdaq: HEPH), a leader in the development of a new class of small molecule compounds based on endogenous adrenal steroid hormones, today announced the board of directors has appointed James M. Frincke Ph.D.

2008-11-07 09:00:25

Hollis-Eden Pharmaceuticals, Inc. (NASDAQ:HEPH) today announced that it has scheduled the following investor conference presentations and webcasts: -- Rodman and Renshaw Annual Global Investment Conference in New York City on November 10, 2008, at 10:20 a.m.

2008-09-30 15:00:17

Hollis-Eden Pharmaceuticals, Inc. Scott Rieger, Vice President, Corporate Communications 858-587-9333 Logo: http://www.holliseden.com Hollis-Eden Pharmaceuticals, Inc.

Word of the Day
  • The parings of haberdine; also, any kind of fragments.
The word 'gubbings' is a variant of the word 'gobbon', meaning 'a portion, gobbet.'